While modern diabetes therapy based on exogenous insulin injection is considered a life-saving treatment for managing the disease, it is unfortunately associated with acute hypoglycemia episodes and weight gain for many patients (Sun et al. 2021b) and not as efficient as the endogenous pancreatic islets for glycemic control. This evidence concerns the gene INS and diabetes mellitus.